GlassScriptPhysician profile
Amit M Khaneja
NPI 1922261486
$2,538.74
in general payments reported to CMS, 2019-2025
21 companies · $403 in 2025
The $403 reported for 2025 was less than what a typical Clinical Neurophysiology provider received nationally (typical 2025 total: $435).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $40.60 · 2020: $24.38 · 2021: $134 · 2022: $832 · 2023: $497 · 2024: $607 · 2025: $403.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,508.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,507.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $871.97 | 2021-2022 | |
| Sk Life Science, INC. | $257.25 | 2023-2025 | |
| Ucb, INC. | $226.40 | 2023-2024 | Briviact |
| Octapharma USA, INC. | $226.40 | 2023-2025 | Balfaxar, Panzyga, Fibryga |
| Astrazeneca Pharmaceuticals LP | $119.43 | 2021-2024 | Andexxa |
| Neurocrine Biosciences, INC. | $114.94 | 2024-2025 | Ingrezza |
| Abbvie INC. | $111.38 | 2023-2025 | |
| Eisai INC. | $102.55 | 2019-2024 | |
| Argenx US, INC. | $78.16 | 2023 | Vyvgart |
| Pfizer INC. | $64.93 | 2023-2025 | |
| Otsuka America Pharmaceutical, INC. | $59.62 | 2023-2025 | Rexulti, Nuedexta |
| Alexion Pharmaceuticals, INC. | $53.02 | 2025 | Ultomiris |
| Janssen Biotech, INC. | $42.45 | 2025 | |
| Biogen, INC. | $35.83 | 2025 | Leqembi |
| Ceribell, INC. | $33.78 | 2025 | Pocket Eeg Device |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Invivyd INC | $30.09 | 2025 | Pemgarda |
| Alnylam Pharmaceuticals INC. | $25.04 | 2023 | Amvuttra |
| Boston Scientific Corporation | $24.38 | 2020 | |
| Neurelis, INC. | $23.92 | 2023 | Valtoco |
| Janssen Pharmaceuticals, INC | $21.60 | 2023 | Xarelto |
| Sunovion Pharmaceuticals INC. | $15.60 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amit Khaneja listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.